NGVT | Ticker Profile - Titan Protect

NGVT

Ingevity Corporation

Basic Materials · Specialty Chemicals · NYQ

$65.99

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.4B

Total market value of the company

Trailing P/E

N/A

Forward P/E

11.98

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.1%

Year-over-year revenue change

Profit Margin

-10.9%

How much profit the company keeps from each dollar of revenue

ROE

-114.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$87.50

+33% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 4 analysts covering this stock

About Ingevity Corporation

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

https://www.ingevity.com

Country: United States Employees: 1,400 Industry: Specialty Chemicals

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.616

Good returns relative to risk taken

Kelly Fraction

0.0512

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

0.499

Drawdown risk outweighs the returns — higher risk profile

Annual Return

20.2%

Historical annualised return based on price data

Max Drawdown

-40.5%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

118

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.24

Moves slightly more than the broader market

52W High

$79.29

17% below the year high

52W Low

$39.74

66% above the year low

Avg Volume

296,636

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

4.2%

Low short interest — limited bearish positioning

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-4.29

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

3,200.00

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.42

Adequate but worth monitoring

Quick Ratio

0.62

Like current ratio but excludes inventory — stricter test

Gross Margin

39.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

26.7%

Profit from core operations before interest and tax

Free Cash Flow

$226M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.2B

Total revenue over the last 12 months

Net Income

$-156,000,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$92.00

Target Median

$87.50

Target Low

$75.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go